Cargando…
Optimal treatment of opioid induced constipation in daily clinical practice – an observational study
BACKGROUND: Opioids are prescribed in over 40% of patients with advanced cancer, but side effects occur frequently. In this study we evaluated the development and treatment of opioid induced constipation (OIC), and OIC resolving effect of methylnaltrexone for different opioid subtypes in daily clini...
Autores principales: | Neefjes, Elisabeth C. W., van der Wijngaart, Hanneke, van der Vorst, Maurice J. D. L., ten Oever, Diederik, van der Vliet, Hans J., Beeker, Aart, Rhodius, Christiaan A., van den Berg, Hendrik P., Berkhof, Johannes, Verheul, Henk M. W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6439982/ https://www.ncbi.nlm.nih.gov/pubmed/30922276 http://dx.doi.org/10.1186/s12904-019-0416-7 |
Ejemplares similares
-
Clinical evaluation of the efficacy of methylnaltrexone in resolving constipation induced by different opioid subtypes combined with laboratory analysis of immunomodulatory and antiangiogenic effects of methylnaltrexone
por: Neefjes, Elisabeth CW, et al.
Publicado: (2014) -
Accuracy of the Delirium Observational Screening Scale (DOS) as a screening tool for delirium in patients with advanced cancer
por: Neefjes, Elisabeth C. W., et al.
Publicado: (2019) -
Identification of patients with cancer with a high risk to develop delirium
por: Neefjes, Elisabeth C. W., et al.
Publicado: (2017) -
Olanzapine Versus Haloperidol for Treatment of Delirium in Patients with Advanced Cancer: A Phase III Randomized Clinical Trial
por: van der Vorst, Maurice J.D.L., et al.
Publicado: (2019) -
Prophylactic treatment for delayed chemotherapy-induced nausea and vomiting after non-AC based moderately emetogenic chemotherapy: a systematic review of randomized controlled trials
por: van der Vorst, Maurice J. D. L, et al.
Publicado: (2015)